TXG logo

10x Genomics (TXG) return on equity

annual ROE:

-25.17%+7.81%(+23.68%)
December 31, 2024

Summary

  • As of today (May 23, 2025), TXG annual return on equity is -25.17%, with the most recent change of +7.81% (+23.68%) on December 31, 2024.
  • During the last 3 years, TXG annual ROE has fallen by -17.69% (-236.50%).
  • TXG annual ROE is now -149.23% below its all-time high of 51.13%, reached on December 31, 2018.

Performance

TXG ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGprofitability metrics

quarterly ROE:

-21.92%+3.33%(+13.19%)
March 31, 2025

Summary

  • As of today (May 23, 2025), TXG quarterly return on equity is -21.92%, with the most recent change of +3.33% (+13.19%) on March 31, 2025.
  • Over the past year, TXG quarterly ROE has increased by +12.85% (+36.96%).
  • TXG quarterly ROE is now -151.02% below its all-time high of 42.96%, reached on March 31, 2019.

Performance

TXG quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

TXG ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+23.7%+37.0%
3 y3 years-236.5%-95.0%
5 y5 years+19.4%+6.0%

TXG ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-236.5%+23.7%-95.0%+37.0%
5 y5-year-236.5%+73.1%-193.1%+77.5%
alltimeall time-149.2%+73.1%-151.0%+84.1%

TXG ROE History

DateAnnualQuarterly
Mar 2025
-
-21.92%(-13.2%)
Dec 2024
-25.17%(-23.7%)
-25.25%(+1.0%)
Sep 2024
-
-24.99%(-22.4%)
Jun 2024
-
-32.21%(-7.4%)
Mar 2024
-
-34.77%(+6.0%)
Dec 2023
-32.98%(+61.3%)
-32.81%(+15.2%)
Sep 2023
-
-28.47%(+30.9%)
Jun 2023
-
-21.75%(-0.8%)
Mar 2023
-
-21.93%(+5.4%)
Dec 2022
-20.45%(+173.4%)
-20.81%(-0.9%)
Sep 2022
-
-20.99%(+17.7%)
Jun 2022
-
-17.84%(+58.7%)
Mar 2022
-
-11.24%(+50.3%)
DateAnnualQuarterly
Dec 2021
-7.48%(-92.0%)
-7.48%(-87.2%)
Sep 2021
-
-58.36%(-19.1%)
Jun 2021
-
-72.16%(-15.6%)
Mar 2021
-
-85.52%(-12.2%)
Dec 2020
-93.64%(+199.7%)
-97.45%(+258.0%)
Sep 2020
-
-27.22%(+15.6%)
Jun 2020
-
-23.55%(+1.0%)
Mar 2020
-
-23.31%(+18.7%)
Dec 2019
-31.24%(-161.1%)
-19.63%(-85.8%)
Sep 2019
-
-137.91%(+3510.2%)
Jun 2019
-
-3.82%(-108.9%)
Mar 2019
-
42.96%(+4.0%)
Dec 2018
51.13%(+206.5%)
41.31%
Dec 2017
16.68%
-

FAQ

  • What is 10x Genomics annual return on equity?
  • What is the all time high annual ROE for 10x Genomics?
  • What is 10x Genomics annual ROE year-on-year change?
  • What is 10x Genomics quarterly return on equity?
  • What is the all time high quarterly ROE for 10x Genomics?
  • What is 10x Genomics quarterly ROE year-on-year change?

What is 10x Genomics annual return on equity?

The current annual ROE of TXG is -25.17%

What is the all time high annual ROE for 10x Genomics?

10x Genomics all-time high annual return on equity is 51.13%

What is 10x Genomics annual ROE year-on-year change?

Over the past year, TXG annual return on equity has changed by +7.81% (+23.68%)

What is 10x Genomics quarterly return on equity?

The current quarterly ROE of TXG is -21.92%

What is the all time high quarterly ROE for 10x Genomics?

10x Genomics all-time high quarterly return on equity is 42.96%

What is 10x Genomics quarterly ROE year-on-year change?

Over the past year, TXG quarterly return on equity has changed by +12.85% (+36.96%)
On this page